GLYCANS FOR DESIGN
Augment Biologics is the first and only AI-powered glycoprotein design company. We use our technology, GlycoTemplating, to engineer glycosylation through targeted amino acid substitutions. We make the glycan layer part of biologic design, with the goal of creating medicines that perform better.
Co-development Opportunities: New & Flagship Biologics
GlycoTemplating creates novel compositions with improved PK & efficacy. Helpful for pre-IND assets and lifecycle management.
Improve Clinically Relevant Drug Behaviors
Asset improvements include durability, Immunogenicity, anti-inflammatory efficacy, liver avoidance, cellular and sub-cellular localization, and biodistribution.
GlycoTemplating Across Biologics Modalities
GlycoTemplating does not require cell or media engineering or exotic chemistry; it uses only amino acid substitutions. GlycoTemplating is therefore compatible with mAb, bi-/tri-specifics, large proteins, vaccines, mRNA, and gene therapy.